PHA ON THE ISSUES: ADVOCACY LETTERS

Comments on Patient Community Priorities for COVID-19 Legislation

Comments on Patient Community Healthcare Priorities for Reconciliation

Comments on Proposed Extension of Arizona Health Care Cost Containment Section 1115 Demonstration Project

South Dakota Should Enact the Patient Protections Outlined in Senate Bill 154

Calling on Congress to Provide Supplemental Funding for NHLBI Research

Calling on the Administration to Address the Shortages of Supplemental Oxygen

Urging the House Ways and Means Committee to Advance COVID-19 Relief Measures

PHA’s 2021 Policy Priorities, Sent to All Members of Congress

Requesting $902 Million in Regular FY2022 Congressional Funding for the VA Medical and Prosthetic Research Program and an Additional $50 Million in Emergency Funding Related to the COVID-19 Pandemic

Patient Groups Strongly Oppose Medicaid Block Grant Approval

Support for Georgia Postpartum Extension Section 1115 Demonstration Waiver Application

Patient Organizations Applaud Strong Actions to Protect People with Pre-existing Conditions

Endorsement of Safe Step Act of 2021

Requesting $4.61 Billion in Funding for the National Institutes of Health in FY2022

PHA Endorsed the “States Achieve Medicaid Expansion Act of 2021 (SAME) Act”

PHA Endorsed the “Protecting Americans with Preexisting Conditions Act”

Patient Groups Applaud Progress, Call on Congress to Permanently End Surprise Medical Billing

Welcome Letter to President-Elect Biden

Response to CMS: Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency

Opposition to the Most Favored Nation (MFN) Model for Medicare Part B Drugs

Comments on Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2022

Comments on HHS Notice of Benefit and Payment Parameters for 2022 and Pharmacy Benefit Manager Standards